Overall, the lack of any significant change in myelin content, microgliosis, or disease severity in the cuprizone and EAE mouse models with global and microglia-specific loss of TRPV4 indicates that TRPV4 is unlikely to play a prominent role in MS pathogenesis. This evidence concerns the gene TRPV4 and myeloid sarcoma.